Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Colorectal Neoplasms

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 288 articles:
HTML format



Single Articles


    September 2020
  1. TAKAHASHI H, Takeda T, Nishizawa Y, Ogino T, et al
    Phase I Study of the Administration of Low-dose Perioperative Human Atrial Natriuretic Peptide in Patients With Resectable Colorectal Cancer.
    Anticancer Res. 2020;40:5301-5307.
    PubMed     Abstract available


  2. NIKOLOVA B, Semkova S, Tsoneva I, Stoyanova E, et al
    Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38.
    Anticancer Res. 2020;40:5159-5170.
    PubMed     Abstract available


  3. MOZOLEWSKA P, Duzowska K, Pakiet A, Mika A, et al
    Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment.
    Anticancer Res. 2020;40:4843-4856.
    PubMed     Abstract available


    August 2020
  4. YAMADA T, Yoshida Y, Maeda T, Yoshimatsu G, et al
    Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy.
    Anticancer Res. 2020;40:4763-4771.
    PubMed     Abstract available


  5. NISHI K, Tsunoda T, Uchida Y, Sueta T, et al
    MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS.
    Anticancer Res. 2020;40:4687-4694.
    PubMed     Abstract available


  6. KUWATA GO, Ikeda K, Manome Y
    Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer.
    Anticancer Res. 2020;40:4505-4511.
    PubMed     Abstract available


  7. KIM BH, Oh HK, Kim DW, Kang SB, et al
    Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
    Anticancer Res. 2020;40:4481-4489.
    PubMed     Abstract available


  8. CHIKATANI K, Chika N, Suzuki O, Sakimoto T, et al
    A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer.
    Anticancer Res. 2020;40:4379-4385.
    PubMed     Abstract available


  9. WANG L, Hirano Y, Heng G, Ishii T, et al
    Better Cancer-specific Survival in Younger Patients With Stage III Colorectal Cancer: A Propensity Score Matching Study From Japan.
    Anticancer Res. 2020;40:4365-4372.
    PubMed     Abstract available


  10. KEIKES L, Koopman M, Lemmens VEPP, VAN Oijen MGH, et al
    Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
    Anticancer Res. 2020;40:4331-4341.
    PubMed     Abstract available


  11. RAMOS-ESQUIVEL A, Chinchilla R, Valle M
    Association of C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine-induced Toxicity in Mestizo Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:4263-4270.
    PubMed     Abstract available


  12. NISHI K, Ishikura S, Umebayashi M, Morisaki T, et al
    Mutant KRAS Promotes NKG2D(+) T Cell Infiltration and CD155 Dependent Immune Evasion.
    Anticancer Res. 2020;40:4663-4674.
    PubMed     Abstract available


  13. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Is Low Inferior Mesenteric Artery Ligation Worthwhile to Prevent Urinary and Sexual Dysfunction After Total Mesorectal Excision for Rectal Cancer?
    Anticancer Res. 2020;40:4223-4228.
    PubMed     Abstract available


    July 2020
  14. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:4157-4163.
    PubMed     Abstract available


  15. POLITO R, Nigro E, Fei L, DE Magistris L, et al
    Adiponectin Is Inversely Associated With Tumour Grade in Colorectal Cancer Patients.
    Anticancer Res. 2020;40:3751-3757.
    PubMed     Abstract available


  16. ENEH S, Heikkinen S, Hartikainen JM, Kuopio T, et al
    MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
    Anticancer Res. 2020;40:3713-3722.
    PubMed     Abstract available


  17. MEKLIN J, SyrjAnen K, Eskelinen M
    Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Anticancer Res. 2020;40:3591-3604.
    PubMed     Abstract available


  18. IGUCHI T, Sugimachi K, Mano Y, Motomura T, et al
    Prognostic Impact of Geriatric Nutritional Risk Index in Patients With Synchronous Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:4165-4171.
    PubMed     Abstract available


  19. VIRGILIO E, Montali F, Costi R, Cavallini M, et al
    Proposal of a Classification System for Adenocarcinoma Involving the Ileocecal Valve (Bauhin's Valve): A Retrospective Study of 689 Right Hemicolectomized Patients.
    Anticancer Res. 2020;40:4053-4057.
    PubMed     Abstract available


  20. CAO C, Parikh P, Moezardalan K, Anantharaman A, et al
    Synchronous Primary Pancreatic Ductal Carcinoma and Colonic Adenocarcinoma Present in a Patient With History of Skin Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4029-4032.
    PubMed     Abstract available


    June 2020
  21. SHIBUTANI M, Nakao S, Maeda K, Nagahara H, et al
    Inflammation Caused by Surgical Stress Has a Negative Impact on the Long-term Survival Outcomes in Patients With Colorectal Cancer.
    Anticancer Res. 2020;40:3535-3542.
    PubMed     Abstract available


  22. MATSUDA A, Yamada T, Jamjittrong S, Shinji S, et al
    Comparison Between Biweekly and Weekly Cetuximab in Patients With Metastatic Colorectal Cancer: A Meta-analysis.
    Anticancer Res. 2020;40:3469-3476.
    PubMed     Abstract available


  23. BAE KB, Kim SH, Kang MS, Kim DH, et al
    An Animal Model of Colorectal Cancer Liver Metastasis With a High Metastasis Rate and Clonal Dynamics.
    Anticancer Res. 2020;40:3297-3306.
    PubMed     Abstract available


  24. TABCHOURI N, Eid Y, Manceau G, Frontali A, et al
    Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity.
    Anticancer Res. 2020;40:3579-3587.
    PubMed     Abstract available


  25. ETO K, Kosuge M, Ohkuma M, Ito D, et al
    Umbilical Defunctioning Ileostomy for Rectal Cancer Results in Reduced Risk for Incisional Hernia.
    Anticancer Res. 2020;40:3445-3451.
    PubMed     Abstract available


    May 2020
  26. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Defecatory Dysfunction After Colon Cancer Resection: The Role of Inferior Mesenteric Artery Tie.
    Anticancer Res. 2020;40:2969-2974.
    PubMed     Abstract available


  27. ALMLOV K, Woisetschlager M, Loftas P, Hallbook O, et al
    MRI Lymph Node Evaluation for Prediction of Metastases in Rectal Cancer.
    Anticancer Res. 2020;40:2757-2763.
    PubMed     Abstract available


  28. KOTNIK N, El-Sourani N, Raap U, Raab HR, et al
    Expression of MicroRNA in Locoregional Recurrent Rectal Cancer.
    Anticancer Res. 2020;40:2947-2953.
    PubMed     Abstract available


    April 2020
  29. WATANABE D, Fujii H, Matsuhashi N, Iihara H, et al
    Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:2379-2386.
    PubMed     Abstract available


  30. ASHIZAWA N, Furuya S, Katsutoshi S, Sudo M, et al
    Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
    Anticancer Res. 2020;40:2311-2317.
    PubMed     Abstract available


  31. HIGASHINO N, Matsuda T, Hasegawa H, Yamashita K, et al
    Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis.
    Anticancer Res. 2020;40:2165-2170.
    PubMed     Abstract available


  32. DE'ANGELIS N, Martinez-Perez A, Vitali GC, Pigneur F, et al
    Predicting Difficult Laparoscopic Total Mesorectal Excision for Locally-advanced Mid-low Rectal Cancer: The EuMaRCS Score Validation.
    Anticancer Res. 2020;40:2079-2087.
    PubMed     Abstract available


  33. TOMORI K, Eto K, Haruki K, Sugano H, et al
    Comparison of Strength of Anastomosis Between Four Different Techniques for Colorectal Surgery.
    Anticancer Res. 2020;40:1891-1896.
    PubMed     Abstract available


  34. NUMATA M, Kazama K, Onodera A, Hara K, et al
    Short-term Outcomes Following Robotic-assisted Laparoscopic Surgery for Technically Demanding Rectal Cancer.
    Anticancer Res. 2020;40:2337-2342.
    PubMed     Abstract available


  35. HIRATA Y, Nozawa H, Kawai K, Hata K, et al
    The Influence of Neoadjuvant Chemoradiation for Middle and Lower Rectal Cancer on Anorectal Function.
    Anticancer Res. 2020;40:2199-2208.
    PubMed     Abstract available


  36. KANG BH, Song C, Kang SB, Lee KW, et al
    Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
    Anticancer Res. 2020;40:2171-2177.
    PubMed     Abstract available


    March 2020
  37. KOJIMA T, Hino H, Shiomi A, Kagawa H, et al
    Surgical Outcomes of Laparoscopic and Open D3 Dissection for Clinical Stage II/III Descending Colon Cancer.
    Anticancer Res. 2020;40:1731-1737.
    PubMed     Abstract available


  38. WANG L, Hirano Y, Heng G, Ishii T, et al
    Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
    Anticancer Res. 2020;40:1651-1659.
    PubMed     Abstract available


  39. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:1605-1611.
    PubMed     Abstract available


  40. KIM HJ, Han YS, Lee JH, Lee SH, et al
    Casein Kinase 2alpha Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
    Anticancer Res. 2020;40:1419-1426.
    PubMed     Abstract available


  41. SARHADI V, Lahti L, Saberi F, Youssef O, et al
    Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.
    Anticancer Res. 2020;40:1325-1334.
    PubMed     Abstract available


  42. HUNG YC, Chang WS, Chou AK, Pei JS, et al
    Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2020;40:1297-1306.
    PubMed     Abstract available


  43. HURLEY PJ, Bose N, Jha G, Gargano M, et al
    Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.
    Anticancer Res. 2020;40:1467-1473.
    PubMed     Abstract available


  44. NAUMANN DN, Ain Q, Evans CFM, Bajwa A, et al
    Factors Affecting Colorectal Polyp and Cancer Detection Rates in Patients Referred Urgently for Suspected Bowel Cancer.
    Anticancer Res. 2020;40:1705-1709.
    PubMed     Abstract available


  45. PALKOVICS A, Vereczkei A, Fincsur A, Kiss I, et al
    Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:1359-1365.
    PubMed     Abstract available


    February 2020
  46. YUN SH, Park JI
    COUP-TFII Overexpression Inhibits Cell Proliferation and Invasion via Increased Expression of p53 and PTEN and Decreased Akt Phosphorylation in Human Colorectal Cancer SNU-C4 Cells.
    Anticancer Res. 2020;40:767-777.
    PubMed     Abstract available


  47. YUN SH, Park JI
    PGC-1alpha Regulates Cell Proliferation and Invasion via AKT/GSK-3beta/beta-catenin Pathway in Human Colorectal Cancer SW620 and SW480 Cells.
    Anticancer Res. 2020;40:653-664.
    PubMed     Abstract available


  48. MEKLIN J, Syrjanen K, Eskelinen M
    Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
    Anticancer Res. 2020;40:575-581.
    PubMed     Abstract available


  49. NAKAMOTO T, Hokuto D, Nomi T, Yoshikawa T, et al
    Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy.
    Anticancer Res. 2020;40:1107-1116.
    PubMed     Abstract available


    January 2020
  50. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Evaluation of Anastomosis With ICG Fluorescence Method Using VISERA ELITE2 During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2020;40:373-377.
    PubMed     Abstract available


  51. WATANABE D, Fujii H, Yamada Y, Iihara H, et al
    Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.
    Anticancer Res. 2020;40:299-304.
    PubMed     Abstract available


  52. HAUS R, Janssen S, Schild SE, Rades D, et al
    A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer.
    Anticancer Res. 2020;40:287-291.
    PubMed     Abstract available


  53. HIRABAYASHI S, Hayashi M, Nakayama G, Mii S, et al
    The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness.
    Anticancer Res. 2020;40:201-211.
    PubMed     Abstract available


  54. YUN SH, Han SH, Park JI
    COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells via Activation of Akt Pathway and Up-regulation of FOXC1.
    Anticancer Res. 2020;40:177-190.
    PubMed     Abstract available


  55. TANAKA T, Kobunai T, Yamamoto Y, Murono K, et al
    Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2020;40:101-107.
    PubMed     Abstract available


  56. OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
    Anticancer Res. 2020;40:169-176.
    PubMed     Abstract available


  57. DORR NM, Bartels M, Morgul MH
    Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.
    Anticancer Res. 2020;40:1-7.
    PubMed     Abstract available


    December 2019
  58. TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
    Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Anticancer Res. 2019;39:6575-6583.
    PubMed     Abstract available


  59. WU MH, Tzeng HE, Wu CN, Yueh TC, et al
    Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
    Anticancer Res. 2019;39:6523-6529.
    PubMed     Abstract available


  60. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:6463-6470.
    PubMed     Abstract available


  61. OGINO Y, Sato A, Kawano Y, Aoyama T, et al
    Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6457-6462.
    PubMed     Abstract available


  62. PETRELLI F, Ghidini M, Cabiddu M, Pezzica E, et al
    Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2019;39:6431-6441.
    PubMed     Abstract available


  63. DE FELICE F, Siniscalchi B, Bulzonetti N, Caiazzo R, et al
    Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
    Anticancer Res. 2019;39:6957-6963.
    PubMed     Abstract available


  64. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
    Anticancer Res. 2019;39:6781-6786.
    PubMed     Abstract available


  65. CIZMARIKOVA M, Takac P, Spengler G, Kincses A, et al
    New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
    Anticancer Res. 2019;39:6499-6505.
    PubMed     Abstract available


  66. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Abstract available


    November 2019
  67. KAYANO H, Nomura E, Ueda Y, Kuramoto T, et al
    Short- and Long-term Outcomes of 2-Step Stapled Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Colectomy for Colon Cancer.
    Anticancer Res. 2019;39:6393-6401.
    PubMed     Abstract available


  68. KATAFYGIOTIS P, Sakellariou S, Chatziandreou I, Giannopoulou I, et al
    Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations.
    Anticancer Res. 2019;39:6379-6387.
    PubMed     Abstract available


  69. HORIUCHI T, Haruki K, Shiba H, Sakamoto T, et al
    Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy.
    Anticancer Res. 2019;39:6325-6332.
    PubMed     Abstract available


  70. HO ML, Kuo WK, Chu LJ, Yeh IH, et al
    N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
    Anticancer Res. 2019;39:6317-6324.
    PubMed     Abstract available


  71. PALAIOLOGOS P, Chrysikos D, Theocharis S, Kouraklis G, et al
    The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
    Anticancer Res. 2019;39:6291-6297.
    PubMed     Abstract available


  72. TREDER M, Janssen S, Schild SE, Rades D, et al
    Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients.
    Anticancer Res. 2019;39:6217-6222.
    PubMed     Abstract available


  73. WU CC, Lai PY, Hsieh S, Cheng CC, et al
    Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6135-6144.
    PubMed     Abstract available


  74. CHANDIMALI N, Sun HN, Kong LZ, Zhen X, et al
    Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.
    Anticancer Res. 2019;39:6115-6123.
    PubMed     Abstract available


  75. KIM HB, Lim HJ, Lee HJ, Park JH, et al
    Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer.
    Anticancer Res. 2019;39:6097-6105.
    PubMed     Abstract available


  76. VYCITAL O, Pitule P, Hosek P, Kriz T, et al
    Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
    Anticancer Res. 2019;39:6063-6066.
    PubMed     Abstract available


  77. BUNDSCHERER AC, Ullrich V, Malsy M, Gruber MA, et al
    Effects of Volatile Anesthetics on Proliferation and Viability of SW480 Colon Cancer Cells In Vitro.
    Anticancer Res. 2019;39:6049-6055.
    PubMed     Abstract available


  78. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:5999-6005.
    PubMed     Abstract available


  79. LEHTOMAKI KI, Lahtinen LI, Rintanen N, Kuopio T, et al
    Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
    Anticancer Res. 2019;39:5867-5877.
    PubMed     Abstract available


  80. CUMBO M, Tomic B, Dunjic S, Jovanovic T, et al
    Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.
    Anticancer Res. 2019;39:6067-6071.
    PubMed     Abstract available


    October 2019
  81. NEKI K, Eto K, Kosuge M, Ohkuma M, et al
    Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
    Anticancer Res. 2019;39:5721-5724.
    PubMed     Abstract available


  82. FIALA O, Ostasov P, Hosek P, Sorejs O, et al
    The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents.
    Anticancer Res. 2019;39:5645-5652.
    PubMed     Abstract available


  83. QIU Z, Andrijauskaite K, Morris J, Wargovich MJ, et al
    Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO2 Extract of Neem Leaf (Azadirachta indica).
    Anticancer Res. 2019;39:5473-5481.
    PubMed     Abstract available


  84. UETA K, Matsuda T, Yamashita K, Hasegawa H, et al
    Treatment Strategy for Rectal Cancer Patients With Inguinal Lymph Node Metastasis.
    Anticancer Res. 2019;39:5767-5772.
    PubMed     Abstract available


  85. SHIBUYA N, Matsuda T, Yamashita K, Hasegawa H, et al
    Clinical Significance of Intraoperative Colonoscopy for Anastomotic Assessment in Rectal Cancer Surgery.
    Anticancer Res. 2019;39:5761-5765.
    PubMed     Abstract available


    September 2019
  86. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Anticancer Res. 2019;39:5039-5045.
    PubMed     Abstract available


  87. DIMBERG J, Shamoun L, Landerholm K, Andersson RE, et al
    Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:4933-4940.
    PubMed     Abstract available


  88. SIGNORELLI C, Chilelli MG, Sperduti I, Giacinti S, et al
    Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
    Anticancer Res. 2019;39:4917-4924.
    PubMed     Abstract available


  89. SEATON ME, Peters U, Johnson KC, Kooperberg C, et al
    Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer.
    Anticancer Res. 2019;39:4877-4884.
    PubMed     Abstract available


  90. YUN CW, Lee JH, Lee SH
    Hypoxia-induced PGC-1alpha Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
    Anticancer Res. 2019;39:4865-4876.
    PubMed     Abstract available


  91. HA YJ, Tak KH, Kim SK, Kim CW, et al
    Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
    Anticancer Res. 2019;39:4853-4864.
    PubMed     Abstract available


  92. KURAMOCHI H, Nakajima GO, Hayashi K, Araida T, et al
    Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer.
    Anticancer Res. 2019;39:4729-4736.
    PubMed     Abstract available


  93. OSHIRO H, Tome Y, Kiyuna T, Yoon SN, et al
    Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:4667-4671.
    PubMed     Abstract available


  94. OHARA T, Mori T
    Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells via Gene Expression Inhibition.
    Anticancer Res. 2019;39:4659-4666.
    PubMed     Abstract available


  95. FUKUOKA T, Maeda K, Nagahara H, Shibutani M, et al
    Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.
    Anticancer Res. 2019;39:5157-5163.
    PubMed     Abstract available


  96. ISKANDER O, Courtot L, Tabchouri N, Artus A, et al
    Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.
    Anticancer Res. 2019;39:5105-5113.
    PubMed     Abstract available


  97. KOMORI K, Kinoshita T, Oshiro T, Ouchi A, et al
    Surgical Strategy for Rectovaginal Fistula After Colorectal Anastomosis at a High-volume Cancer Center According to Image Type and Colonoscopy Findings.
    Anticancer Res. 2019;39:5097-5103.
    PubMed     Abstract available


  98. MORINE Y, Ikemoto T, Iwahashi S, Saito YU, et al
    Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.
    Anticancer Res. 2019;39:5089-5096.
    PubMed     Abstract available


  99. RUBIO CA, Schmidt PT
    The Normal Epithelium of Crypts Accruing Below Nonpolypoid Adenomas Thrives With Relocated Proliferating Cell-domains and p53-Up-regulated Cells.
    Anticancer Res. 2019;39:4965-4970.
    PubMed     Abstract available


  100. LUCERI C, Femia AP, D'Ambrosio M, Caderni G, et al
    High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apc(am1137)) a Suitable Model for Studying CRC-promoting Agents.
    Anticancer Res. 2019;39:4673-4679.
    PubMed     Abstract available


    August 2019
  101. HISAKA T, Ishikawa H, Sakai H, Kawahara R, et al
    Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.
    Anticancer Res. 2019;39:4549-4554.
    PubMed     Abstract available


  102. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
    Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
    Anticancer Res. 2019;39:4525-4532.
    PubMed     Abstract available


  103. ASHIZAWA N, Shimizu H, Sudo M, Furuya S, et al
    Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.
    Anticancer Res. 2019;39:4405-4410.
    PubMed     Abstract available


  104. MATSUDA A, Yamada T, Matsumoto S, Sakurazawa N, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:4343-4350.
    PubMed     Abstract available


  105. ITO Y, Kobuchi S, Takesada W, Takahashi C, et al
    Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer.
    Anticancer Res. 2019;39:4207-4213.
    PubMed     Abstract available


  106. YOON SN, Park JH, Lwin TM, Miyake K, et al
    Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
    Anticancer Res. 2019;39:4065-4071.
    PubMed     Abstract available


  107. NAYERI M, Iskander O, Tabchouri N, Artus A, et al
    Low Tie Compared to High Tie Vascular Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery Decreases Postoperative Complications Without Affecting Overall Survival.
    Anticancer Res. 2019;39:4363-4370.
    PubMed     Abstract available


  108. RUBIO CA, Schmidt PT
    Dissecting the Microscopic Anatomy of Colon Crypts in Non-dysplastic Sessile Serrated Polyps.
    Anticancer Res. 2019;39:4259-4263.
    PubMed     Abstract available


    July 2019
  109. GIULIANI J, Bonetti A
    The Onset of Grade >/=3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil.
    Anticancer Res. 2019;39:3967-3969.
    PubMed     Abstract available


  110. CZUMAJ A, Zabielska J, Pakiet A, Mika A, et al
    In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.
    Anticancer Res. 2019;39:3815-3822.
    PubMed     Abstract available


  111. LIU Y, Kwon T, Kim JS, Chandimali N, et al
    Peroxiredoxin V Reduces beta-Lapachone-induced Apoptosis of Colon Cancer Cells.
    Anticancer Res. 2019;39:3677-3686.
    PubMed     Abstract available


  112. KIM JY, Park G, Krishnan M, Ha E, et al
    Selective Wnt/beta-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
    Anticancer Res. 2019;39:3661-3667.
    PubMed     Abstract available


  113. KOBUNAI T, Matsuoka K, Takechi T
    ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro.
    Anticancer Res. 2019;39:3565-3570.
    PubMed     Abstract available


  114. PARK JH, Zhao M, Oshiro H, Miyake K, et al
    Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
    Anticancer Res. 2019;39:3463-3467.
    PubMed     Abstract available


  115. VUJIC J, Schollnast H, Marsoner K, Wienerroither V, et al
    Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
    Anticancer Res. 2019;39:3847-3854.
    PubMed     Abstract available


  116. PATTAYIL L, Balakrishnan-Saraswathi HT
    In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells.
    Anticancer Res. 2019;39:3795-3801.
    PubMed     Abstract available


    June 2019
  117. ETO S, Kawahara H, Matsumoto T, Hirabayashi T, et al
    Preoperative Neutrophil-Lymphocyte Ratio Is a Predictor of Bowel Obstruction Due to Colorectal Cancer Growth.
    Anticancer Res. 2019;39:3185-3189.
    PubMed     Abstract available


  118. VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
    Curative and Prophylactic Surgery of Young-onset Colorectal Cancer in Inherited Syndromes: A 15-Year Monocentric Retrospective Experience.
    Anticancer Res. 2019;39:3131-3136.
    PubMed     Abstract available


  119. MOKKARALA M, Noda C, Malone C, Ramaswamy R, et al
    Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.
    Anticancer Res. 2019;39:3071-3077.
    PubMed     Abstract available


  120. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Real-Time Fluorescence Vessel Navigation Using Indocyanine Green During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2019;39:3009-3013.
    PubMed     Abstract available


  121. ISHIKAWA D, Takasu C, Kashihara H, Nishi M, et al
    The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:2855-2860.
    PubMed     Abstract available


  122. WU MH, Hung YW, Gong CL, Chao CC, et al
    Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
    Anticancer Res. 2019;39:2791-2797.
    PubMed     Abstract available


  123. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
    The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Anticancer Res. 2019;39:2689-2697.
    PubMed     Abstract available


  124. JUNGINGER T, Goenner U, Trinh TT, Heintz A, et al
    The Link Between Local Recurrence and Distant Metastases in Patients With Rectal Cancer.
    Anticancer Res. 2019;39:3079-3088.
    PubMed     Abstract available


  125. TAKEDA M, Kawahara H, Ogawa M, Suwa K, et al
    Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Anticancer Res. 2019;39:3047-3052.
    PubMed     Abstract available


  126. PALUMBO P, Usai S, Pansa A, Lucchese S, et al
    Anastomotic Leakage in Rectal Surgery: Role of the Ghost Ileostomy.
    Anticancer Res. 2019;39:2975-2983.
    PubMed     Abstract available


  127. YOON G, Park JY, Kim HJ, Choi GS, et al
    ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2019;39:2845-2853.
    PubMed     Abstract available


  128. TANIYAMA D, Taniyama K, Kuraoka K, Yamamoto H, et al
    CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma.
    Anticancer Res. 2019;39:2767-2775.
    PubMed     Abstract available


    May 2019
  129. RADES D, Hansen HC, Janssen S, Schild SE, et al
    Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
    Anticancer Res. 2019;39:2569-2574.
    PubMed     Abstract available


  130. OGAWA H, Kaira K, Motegi Y, Yokobori T, et al
    Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Anticancer Res. 2019;39:2535-2543.
    PubMed     Abstract available


  131. ANGELOU A, Antoniou E, Pikouli A, Wang J, et al
    Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse Model.
    Anticancer Res. 2019;39:2443-2446.
    PubMed     Abstract available


  132. MANTSO T, Vasileiadis S, Lampri E, Botaitis S, et al
    Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma.
    Anticancer Res. 2019;39:2307-2315.
    PubMed     Abstract available


    April 2019
  133. RALLIS G, Koletsa T, Saridaki Z, Manousou K, et al
    Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
    Anticancer Res. 2019;39:2129-2138.
    PubMed     Abstract available


  134. HAMADA K, Otsubo R, Takeshita H, Nonaka T, et al
    Diagnosis of Lymph Node Metastasis in Colorectal Cancer by a Semi-dry Dot-blot Method.
    Anticancer Res. 2019;39:2069-2076.
    PubMed     Abstract available


  135. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
    Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:1953-1957.
    PubMed     Abstract available


  136. ALAGARATNAM S, Yang SY, Loizidou M, Fuller B, et al
    Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.
    Anticancer Res. 2019;39:1705-1710.
    PubMed     Abstract available


  137. FRANSGAARD T, Hallas J, Thygesen LC, Gogenur I, et al
    Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
    Anticancer Res. 2019;39:2177-2182.
    PubMed     Abstract available


  138. PETRUCCIANI N, Carra MC, Martinez-Perez A, Vitali GC, et al
    Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Anticancer Res. 2019;39:2113-2120.
    PubMed     Abstract available


  139. SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
    Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
    Anticancer Res. 2019;39:1997-2005.
    PubMed     Abstract available


  140. PINELLI A, Ferrario P, Trivulzio S
    Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
    Anticancer Res. 2019;39:1807-1812.
    PubMed     Abstract available


  141. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
    The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Anticancer Res. 2019;39:1719-1728.
    PubMed     Abstract available


    March 2019
  142. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
    Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
    Anticancer Res. 2019;39:1425-1432.
    PubMed     Abstract available


  143. NAGATA T, Fukuda KI, Tamai M, Taniguchi A, et al
    Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
    Anticancer Res. 2019;39:1347-1353.
    PubMed     Abstract available


  144. YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
    Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
    Anticancer Res. 2019;39:1301-1308.
    PubMed     Abstract available


  145. LI CC, Liang JA, Chung CY, Chen WT, et al
    Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
    Anticancer Res. 2019;39:1479-1484.
    PubMed     Abstract available


  146. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
    Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
    Anticancer Res. 2019;39:1343-1346.
    PubMed     Abstract available


  147. REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
    ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
    Anticancer Res. 2019;39:1267-1273.
    PubMed     Abstract available


    February 2019
  148. YAMAMOTO M, Saito H, Uejima C, Tanio A, et al
    Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer.
    Anticancer Res. 2019;39:1085-1090.
    PubMed     Abstract available


  149. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
    Anticancer Res. 2019;39:1051-1057.
    PubMed     Abstract available


  150. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
    Anticancer Res. 2019;39:1029-1034.
    PubMed     Abstract available


  151. SMOLLE MA, Kashofer K, Riedl JM, Stotz M, et al
    Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
    Anticancer Res. 2019;39:847-852.
    PubMed     Abstract available


  152. SRODA-POMIANEK K, Michalak K, Palko-Labuz A, Uryga A, et al
    Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
    Anticancer Res. 2019;39:727-734.
    PubMed     Abstract available


  153. BAE GE, DO SI, Kim K, Park JH, et al
    Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:663-670.
    PubMed     Abstract available


  154. LEE D, Matsuda T, Yamashita K, Hasegawa H, et al
    Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
    Anticancer Res. 2019;39:993-998.
    PubMed     Abstract available


  155. RUBIO CA, Schmidt PT
    Crypts With Corrupted Shapes in Non-polypoid Adenomas.
    Anticancer Res. 2019;39:833-838.
    PubMed     Abstract available


  156. OZTOP S, Isik A, Guner G, Gurdal H, et al
    Class III beta-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response.
    Anticancer Res. 2019;39:655-662.
    PubMed     Abstract available


    January 2019
  157. KEARNEY MR, Chen EY, Vaccaro GM, Strother J, et al
    A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:245-252.
    PubMed     Abstract available


  158. SHIMIZU D, Masuda T, Sato K, Tsuruda Y, et al
    CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
    Anticancer Res. 2019;39:99-106.
    PubMed     Abstract available


  159. KUDOU M, Arita T, Nakanishi M, Kuriu Y, et al
    Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
    Anticancer Res. 2019;39:505-510.
    PubMed     Abstract available


  160. GUIMARAES DP, Fregnani JH, Reis RM, Taveira LN, et al
    Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Anticancer Res. 2019;39:261-269.
    PubMed     Abstract available


  161. WAKUI M, Kawai K, Mizushima T, Nishime C, et al
    Fatty Acid beta-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia.
    Anticancer Res. 2019;39:191-200.
    PubMed     Abstract available


  162. MUTO Y, Furihata T, Kaneko M, Higuchi K, et al
    Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.
    Anticancer Res. 2019;39:159-165.
    PubMed     Abstract available


  163. GUDUR A, Shanmuganandamurthy D, Szep Z, Poggio JL, et al
    An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia.
    Anticancer Res. 2019;39:17-23.
    PubMed     Abstract available


    December 2018
  164. SHIBUYA N, Ishizuka M, Takagi K, Iwasaki Y, et al
    Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.
    Anticancer Res. 2018;38:6783-6788.
    PubMed     Abstract available


  165. MATSUTANI S, Shibutani M, Maeda K, Nagahara H, et al
    Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
    Anticancer Res. 2018;38:6721-6727.
    PubMed     Abstract available


  166. KOH HK, Kim K, Jang WI, Song CH, et al
    Radiation Therapy for Anal Squamous Cell Carcinoma: A Retrospective Multicenter Study.
    Anticancer Res. 2018;38:6931-6938.
    PubMed     Abstract available


  167. LEE JH, Song C, Kang SB, Lee HS, et al
    Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2018;38:6905-6910.
    PubMed     Abstract available


  168. KIM J, Ahn S, Kim K, Cho MS, et al
    Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:6881-6889.
    PubMed     Abstract available


  169. RADES D, Vogelsang RP, Treder M, Janssen S, et al
    A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
    Anticancer Res. 2018;38:6877-6880.
    PubMed     Abstract available


  170. MORELLI C, Formica V, Pellicori S, Menghi A, et al
    Chemotherapy in Patients with Hereditary Angioedema.
    Anticancer Res. 2018;38:6801-6807.
    PubMed     Abstract available


    November 2018
  171. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
    Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
    Anticancer Res. 2018;38:6399-6404.
    PubMed     Abstract available


  172. MASUDA T, Margonis GA, Andreatos N, Wang J, et al
    Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
    Anticancer Res. 2018;38:6353-6360.
    PubMed     Abstract available


  173. ENKHBAT T, Nishi M, Yoshikawa K, Jun H, et al
    Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy.
    Anticancer Res. 2018;38:6247-6252.
    PubMed     Abstract available


  174. DA SILVA MACHADO F, Munari FM, Scariot FJ, Echeverrigaray S, et al
    Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.
    Anticancer Res. 2018;38:6231-6236.
    PubMed     Abstract available


  175. SUEHIRO Y, Takemoto Y, Nishimoto A, Ueno K, et al
    Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
    Anticancer Res. 2018;38:6225-6230.
    PubMed     Abstract available


  176. SEMAAN C, Neilson KA, Brown B, Molloy MP, et al
    Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
    Anticancer Res. 2018;38:6195-6200.
    PubMed     Abstract available


  177. NAKURTE I, Jekabsons K, Rembergs R, Zandberga E, et al
    Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
    Anticancer Res. 2018;38:6133-6138.
    PubMed     Abstract available


  178. WANG B, Ogata H, Takishima Y, Miyamoto S, et al
    A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
    Anticancer Res. 2018;38:6121-6126.
    PubMed     Abstract available


  179. MASUISHI T, Taniguchi H, Eto T, Komori A, et al
    Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.
    Anticancer Res. 2018;38:6501-6506.
    PubMed     Abstract available


  180. PALKOVICS A, Vereczkei A, Kalmar KN, Fincsur A, et al
    The Issue of Survival After Colorectal Liver Metastasis Surgery: Parenchyma Sparing vs. Radicality.
    Anticancer Res. 2018;38:6431-6438.
    PubMed     Abstract available


    October 2018
  181. KAMIZA AB, Wang WC, You JF, Tang R, et al
    EGFR, SMAD7, and TGFBR2 Polymorphisms Are Associated with Colorectal Cancer in Patients with Lynch Syndrome.
    Anticancer Res. 2018;38:5983-5990.
    PubMed     Abstract available


  182. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
    Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer.
    Anticancer Res. 2018;38:5889-5895.
    PubMed     Abstract available


  183. KIM JN, Kim TH, Yoon JH, Cho SG, et al
    Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A.
    Anticancer Res. 2018;38:5791-5798.
    PubMed     Abstract available


  184. SINGH B, Singh G, Pourgholami M, Alzahrani N, et al
    Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy.
    Anticancer Res. 2018;38:5917-5921.
    PubMed     Abstract available


  185. MURATA H, Okamoto M, Takahashi T, Motegi M, et al
    SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.
    Anticancer Res. 2018;38:5909-5916.
    PubMed     Abstract available


  186. DE CESARE M
    High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
    Anticancer Res. 2018;38:5783-5790.
    PubMed     Abstract available


  187. AKAMINE T, Morodomi Y, Harada Y, Teraishi K, et al
    miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.
    Anticancer Res. 2018;38:5693-5701.
    PubMed     Abstract available


    September 2018
  188. JORDAN F, Grundmann N, Schenkirsch G, Markl B, et al
    Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer.
    Anticancer Res. 2018;38:5539-5546.
    PubMed     Abstract available


  189. KAWAHARA H, Yoshida S, Tohyama Y, Yanagisawa S, et al
    Serum Carcinoembryonic Antigen Levels Before the First Curative Hepatectomy for Metastatic Colorectal Cancer Is a Predictor of Recurrence.
    Anticancer Res. 2018;38:5351-5355.
    PubMed     Abstract available


  190. ENDZELINS E, Abols A, Buss A, Zandberga E, et al
    Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells.
    Anticancer Res. 2018;38:5139-5147.
    PubMed     Abstract available


  191. LEA MA, Kim H, desBORDES C
    Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
    Anticancer Res. 2018;38:5003-5011.
    PubMed     Abstract available


  192. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
    Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
    Anticancer Res. 2018;38:5531-5537.
    PubMed     Abstract available


  193. PARK CK, Kim HS
    Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor.
    Anticancer Res. 2018;38:5465-5473.
    PubMed     Abstract available


  194. HEINZE C, Omari J, Othmer M, Hass P, et al
    Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5401-5407.
    PubMed     Abstract available


  195. TREDER M, Janssen S, Hollander NH, Schild SE, et al
    Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.
    Anticancer Res. 2018;38:5371-5377.
    PubMed     Abstract available


  196. RUBIO CA, Schmidt PT
    Are Non-dysplastic Crypts with Corrupted Shapes the Initial Recordable Histological Event in the Development of Sporadic Conventional Adenomas?
    Anticancer Res. 2018;38:5315-5320.
    PubMed     Abstract available


    August 2018
  197. DAITOKU N, Miyamoto Y, Tokunaga R, Sakamoto Y, et al
    Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
    Anticancer Res. 2018;38:4883-4888.
    PubMed     Abstract available


  198. ARAKAWA K, Hata K, Kawai K, Tanaka T, et al
    Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
    Anticancer Res. 2018;38:4871-4876.
    PubMed     Abstract available


  199. HIRAYAMA K, Sudoh M, Shimizu H, Furuya S, et al
    Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
    Anticancer Res. 2018;38:4797-4803.
    PubMed     Abstract available


  200. KARLBERG M, Stenstedt K, Hallstrom M, Ragnhammar P, et al
    Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.
    Anticancer Res. 2018;38:4713-4721.
    PubMed     Abstract available


  201. SIM JJ, Park MH, Baek JH, Lee H, et al
    Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling.
    Anticancer Res. 2018;38:4667-4676.
    PubMed     Abstract available


  202. LIU W, Zhang D, Tan SA, Liu X, et al
    Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
    Anticancer Res. 2018;38:4847-4852.
    PubMed     Abstract available


  203. LEE YM, Yeo MK, Seong IO, Kim KH, et al
    Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma.
    Anticancer Res. 2018;38:4819-4826.
    PubMed     Abstract available


  204. MIYAKITA H, Sadahiro S, Kamei Y, Ogimi T, et al
    Chemoradiotherapy-induced Changes in Mucinous Components in Rectal Cancer Tissue: Evaluation on High Iron Diamine-alcian Blue and Mucin 1 Staining.
    Anticancer Res. 2018;38:4783-4787.
    PubMed     Abstract available


  205. TUTINO V, DE Nunzio V, Tafaro A, Bianco G, et al
    Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.
    Anticancer Res. 2018;38:4485-4491.
    PubMed     Abstract available


  206. NAKAMURA M, Suetsugu A, Hasegawa K, Satake T, et al
    Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
    Anticancer Res. 2018;38:4417-4423.
    PubMed     Abstract available


    July 2018
  207. YOSHIDA Y, Sakamoto R, Kajitani R, Munechika T, et al
    Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer.
    Anticancer Res. 2018;38:4367-4373.
    PubMed     Abstract available


  208. LUO H, Nishi K, Ishikura S, Swain A, et al
    Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture.
    Anticancer Res. 2018;38:4247-4256.
    PubMed     Abstract available


  209. YUN CW, Kim S, Lee JH, Lee SH, et al
    Melatonin Promotes Apoptosis of Colorectal Cancer Cells via Superoxide-mediated ER Stress by Inhibiting Cellular Prion Protein Expression.
    Anticancer Res. 2018;38:3951-3960.
    PubMed     Abstract available


  210. CHABOWSKI M, Nowak A, Grzegrzolka J, Piotrowska A, et al
    Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer.
    Anticancer Res. 2018;38:3889-3895.
    PubMed     Abstract available


  211. RUBIO CA, Schmidt PT
    Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer.
    Anticancer Res. 2018;38:3811-3815.
    PubMed     Abstract available


  212. MAEDA K, Shibutani M, Otani H, Fukuoka T, et al
    Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study.
    Anticancer Res. 2018;38:4193-4197.
    PubMed     Abstract available


  213. VYCITAL O, Dubova M, Palek R, Hosek P, et al
    The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
    Anticancer Res. 2018;38:4159-4167.
    PubMed     Abstract available


  214. TUPY R, Mirka H, Mracek J, Priban V, et al
    Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
    Anticancer Res. 2018;38:4149-4152.
    PubMed     Abstract available


  215. KIM S, Park SG, Song YJ, Park JK, et al
    Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.
    Anticancer Res. 2018;38:3853-3861.
    PubMed     Abstract available


    June 2018
  216. SAWAZAKI S, Numata M, Morita J, Maezawa Y, et al
    Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
    Anticancer Res. 2018;38:3767-3772.
    PubMed     Abstract available


  217. VENALAINEN MK, Roine AN, Hakkinen MR, Vepsalainen JJ, et al
    Altered Polyamine Profiles in Colorectal Cancer.
    Anticancer Res. 2018;38:3601-3607.
    PubMed     Abstract available


  218. ENKHBAT T, Nishi M, Takasu C, Yoshikawa K, et al
    Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
    Anticancer Res. 2018;38:3367-3373.
    PubMed     Abstract available


  219. OKUNO T, Kawai K, Hata K, Murono K, et al
    SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1alpha.
    Anticancer Res. 2018;38:3323-3331.
    PubMed     Abstract available


  220. ANGELOU A, Andreatos N, Antoniou E, Zacharioudaki A, et al
    A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.
    Anticancer Res. 2018;38:3467-3470.
    PubMed     Abstract available


  221. LING G, Lamprecht S, Shubinsky G, Osyntsov L, et al
    Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
    Anticancer Res. 2018;38:3333-3339.
    PubMed     Abstract available


    May 2018
  222. RADES D, Dziggel L, Blanck O, Gebauer N, et al
    A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
    Anticancer Res. 2018;38:3111-3114.
    PubMed     Abstract available


  223. TEI M, Otsuka M, Suzuki Y, Kishi K, et al
    Safety and Feasibility of Single-port Surgery for Colon Cancer in Octogenarians.
    Anticancer Res. 2018;38:2967-2972.
    PubMed     Abstract available


  224. PATANKAR M, Vayrynen S, Tuomisto A, Makinen M, et al
    Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.
    Anticancer Res. 2018;38:2915-2921.
    PubMed     Abstract available


  225. DESHWAR A, Margonis GA, Andreatos N, Barbon C, et al
    Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
    Anticancer Res. 2018;38:2891-2895.
    PubMed     Abstract available


  226. CACEV T, Zapletal E, Musani V, Rako I, et al
    Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.
    Anticancer Res. 2018;38:2841-2848.
    PubMed     Abstract available


  227. TUTINO V, Defrancesco ML, Tolomeo M, DE Nunzio V, et al
    The Expression of Riboflavin Transporters in Human Colorectal Cancer.
    Anticancer Res. 2018;38:2659-2667.
    PubMed     Abstract available


  228. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
    Effect of Tissue Factor on Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:2635-2642.
    PubMed     Abstract available


  229. ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
    Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
    Anticancer Res. 2018;38:3069-3077.
    PubMed     Abstract available


  230. CUSHMAN TR, Venigalla S, Brooks ED, Lin C, et al
    Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
    Anticancer Res. 2018;38:2923-2927.
    PubMed     Abstract available


  231. JOO JW, Kim HS, Do SI, Sung JY, et al
    Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
    Anticancer Res. 2018;38:2787-2792.
    PubMed     Abstract available


    April 2018
  232. KAWAHARA H, Mouri T, Ishida K, Matsumoto N, et al
    Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer.
    Anticancer Res. 2018;38:2419-2422.
    PubMed     Abstract available


  233. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
    Anticancer Res. 2018;38:2031-2035.
    PubMed     Abstract available


  234. LIN KM, Yang MD, Tsai CW, Chang WS, et al
    The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2018;38:2001-2006.
    PubMed     Abstract available


  235. LEE JH, Yoon YM, Han YS, Yun CW, et al
    Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
    Anticancer Res. 2018;38:1993-2000.
    PubMed     Abstract available


  236. WANG W, Li Y, Chen Y, Chen H, et al
    Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.
    Anticancer Res. 2018;38:1917-1925.
    PubMed     Abstract available


  237. RUBIO CA, Schmidt PT
    Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
    Anticancer Res. 2018;38:2253-2259.
    PubMed     Abstract available


  238. SIDERIS M, Donaldson AN, Hanrahan J, Grunwald M, et al
    Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.
    Anticancer Res. 2018;38:1879-1895.
    PubMed     Abstract available


    March 2018
  239. ETO K, Kosuge M, Ohkuma M, Noaki R, et al
    Defunctioning Ileostomy Is a Key Risk Factor for Small Bowel Obstruction After Colorectal Cancer Resection.
    Anticancer Res. 2018;38:1789-1795.
    PubMed     Abstract available


  240. FURUKE H, Komatsu S, Ikeda J, Tanaka S, et al
    Self-expandable Metallic Stents Contribute to Reducing Perioperative Complications in Colorectal Cancer Patients with Acute Obstruction.
    Anticancer Res. 2018;38:1749-1753.
    PubMed     Abstract available


  241. SUENAGA M, Akiyoshi T, Shinozaki E, Fujimoto Y, et al
    A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study.
    Anticancer Res. 2018;38:1741-1747.
    PubMed     Abstract available


  242. OKUGAWA Y, Shirai Y, Toiyama Y, Saigusa S, et al
    Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
    Anticancer Res. 2018;38:1599-1610.
    PubMed     Abstract available


  243. CHEN Y, Lee CH, Tseng BY, Tsai YH, et al
    AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting mTOR and Cell-cycle Progression.
    Anticancer Res. 2018;38:1445-1454.
    PubMed     Abstract available


  244. BABA T, Kokuryo T, Yamaguchi J, Yokoyama Y, et al
    Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
    Anticancer Res. 2018;38:1427-1434.
    PubMed     Abstract available


  245. NA K, Sung JY, Kim HS
    Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum.
    Anticancer Res. 2018;38:1767-1774.
    PubMed     Abstract available


  246. YOSHIKAWA K, Shimada M, Higashijima J, Nakao T, et al
    Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:1735-1739.
    PubMed     Abstract available


  247. KERR D, Laber D, Visweshwar N, Jaglal M, et al
    Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin.
    Anticancer Res. 2018;38:1711-1713.
    PubMed     Abstract available


  248. LACZMANSKA I, Sasiadek M, Laczmanski L
    The Comparison Between Molecular Tumour Profiling in Microdissected and Surgical Tissue Samples.
    Anticancer Res. 2018;38:1415-1418.
    PubMed     Abstract available


    February 2018
  249. SHINAGAWA T, Hata K, Morikawa T, Takiyama H, et al
    Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.
    Anticancer Res. 2018;38:993-1002.
    PubMed     Abstract available


  250. NUMATA M, Sawazaki S, Morita J, Maezawa Y, et al
    Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
    Anticancer Res. 2018;38:963-967.
    PubMed     Abstract available


  251. KANG S, Oh SC, Min BW, Lee DH, et al
    Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:787-794.
    PubMed     Abstract available


  252. OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
    Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
    Anticancer Res. 2018;38:737-743.
    PubMed     Abstract available


  253. HAUSMANN D, Liu J, Budjan J, Reichert M, et al
    Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
    Anticancer Res. 2018;38:969-978.
    PubMed     Abstract available


  254. RUBIO CA, DE Petris G, Puppa G
    Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis.
    Anticancer Res. 2018;38:919-921.
    PubMed     Abstract available


  255. BUNDSCHERER AC, Malsy M, Gruber MA, Graf BM, et al
    Acetaminophen and Metamizole Induce Apoptosis in HT 29 and SW 480 Colon Carcinoma Cell Lines In Vitro.
    Anticancer Res. 2018;38:745-751.
    PubMed     Abstract available


  256. JUNG YY, Sung JY, Kim JY, Kim HS, et al
    Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
    Anticancer Res. 2018;38:691-697.
    PubMed     Abstract available


  257. LUNDBERG IV, Wikberg ML, Ljuslinder I, Li X, et al
    MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.
    Anticancer Res. 2018;38:677-683.
    PubMed     Abstract available


  258. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
    The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
    Anticancer Res. 2018;38:811-816.
    PubMed     Abstract available


    January 2018
  259. KATSUKI T, Nakayama Y, Akiyama M, Sawatsubashi Y, et al
    Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
    Anticancer Res. 2018;38:569-575.
    PubMed     Abstract available


  260. TAKAHASHI H, Haraguchi N, Nishimura J, Hata T, et al
    The Severity of Anastomotic Leakage May Negatively Impact the Long-term Prognosis of Colorectal Cancer.
    Anticancer Res. 2018;38:533-539.
    PubMed     Abstract available


  261. MIYAMOTO Y, Oki E, Emi Y, Tokunaga S, et al
    Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
    Anticancer Res. 2018;38:491-499.
    PubMed     Abstract available


  262. SHAMOUN L, Kolodziej B, Andersson RE, Dimberg J, et al
    Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.
    Anticancer Res. 2018;38:321-328.
    PubMed     Abstract available


  263. JO YK, Park NY, Shin JH, Jo DS, et al
    Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells.
    Anticancer Res. 2018;38:271-277.
    PubMed     Abstract available


  264. YANG G, Qiu J, Wang D, Tao Y, et al
    Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
    Anticancer Res. 2018;38:131-136.
    PubMed     Abstract available


  265. MURONO K, Kawai K, Hata K, Emoto S, et al
    Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Anticancer Res. 2018;38:15-22.
    PubMed     Abstract available


  266. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Abstract available


  267. GLEI M, Fischer S, Lamberty J, Ludwig D, et al
    Chemopreventive Potential of In Vitro Fermented Raw and Roasted Hazelnuts in LT97 Colon Adenoma Cells.
    Anticancer Res. 2018;38:83-93.
    PubMed     Abstract available


    December 2017
  268. LIANG YH, Shao YY, Chen HM, Cheng AL, et al
    Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
    Anticancer Res. 2017;37:7095-7104.
    PubMed     Abstract available


  269. GKEKAS I, Novotny J, Pecen L, Strigard K, et al
    Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Anticancer Res. 2017;37:6563-6574.
    PubMed     Abstract available


  270. YAMAMOTO S, Kanai T, Osumi K, Yo K, et al
    Anastomotic Leakage Using Linear Stapling Device with Pre-attached Bioabsorbable Polyglycolic Acid Felt After Laparoscopic Anterior Resection.
    Anticancer Res. 2017;37:7083-7086.
    PubMed     Abstract available


  271. MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
    A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
    Anticancer Res. 2017;37:7069-7071.
    PubMed     Abstract available


  272. RUBIO CA
    Updated Histologic Classification of Adenomas and Carcinomas in the Colon of Carcinogen-treated Sprague-Dawley Rats.
    Anticancer Res. 2017;37:6667-6670.
    PubMed     Abstract available


    November 2017
  273. KAJITANI T, Makiyama A, Arita S, Shimokawa H, et al
    Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:6459-6468.
    PubMed     Abstract available


  274. MERCIER J, Voutsadakis IA
    A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:5925-5934.
    PubMed     Abstract available


  275. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
    Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
    Anticancer Res. 2017;37:6489-6494.
    PubMed     Abstract available


    October 2017
  276. TAKIYAMA A, Tanaka T, Yamamoto Y, Hata K, et al
    Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms.
    Anticancer Res. 2017;37:5785-5790.
    PubMed     Abstract available


  277. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
    Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
    Anticancer Res. 2017;37:5449-5458.
    PubMed     Abstract available


  278. TANASE T, Hamada C, Yoshino T, Ohtsu A, et al
    A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer.
    Anticancer Res. 2017;37:5851-5855.
    PubMed     Abstract available


  279. IDE S, Toiyama Y, Okugawa Y, Oki S, et al
    Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
    Anticancer Res. 2017;37:5797-5804.
    PubMed     Abstract available


  280. KAWAHARA H, Akiba T, Yanaga K
    Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
    Anticancer Res. 2017;37:5767-5769.
    PubMed     Abstract available


  281. TOKUNAGA T, Nishi M, Higashijima J, Yoshikawa K, et al
    Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
    Anticancer Res. 2017;37:5617-5622.
    PubMed     Abstract available


  282. SUNG JY, Na K, Kim HS
    Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
    Anticancer Res. 2017;37:5525-5531.
    PubMed     Abstract available


  283. IKEMURA M, Hashida T
    Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil.
    Anticancer Res. 2017;37:5463-5468.
    PubMed     Abstract available


    September 2017
  284. KANEKO M, Nozawa H, Emoto S, Murono K, et al
    Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
    Anticancer Res. 2017;37:5155-5160.
    PubMed     Abstract available


  285. ANNEDE P, Darreon J, Benkemouche A, Valdenaire S, et al
    Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy.
    Anticancer Res. 2017;37:5133-5139.
    PubMed     Abstract available


  286. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
    Clinical and Oncological Outcomes of Laparoscopic Lateral Pelvic Lymph Node Dissection in Advanced Lower Rectal Cancer: Single-institution Experience.
    Anticancer Res. 2017;37:5095-5100.
    PubMed     Abstract available


  287. CARINI F, Mazzola M, Rappa F, Jurjus A, et al
    Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
    Anticancer Res. 2017;37:4759-4766.
    PubMed     Abstract available


  288. BAR JK, Lis-Nawara A, Grelewski P, Noga L, et al
    The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to KRAS Gene Status.
    Anticancer Res. 2017;37:4953-4960.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: